Related Experiment Video
Updated: Jul 26, 2025

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by
Haibao Peng1, Feibai Yao1, Jiaxu Zhao1
1Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science Fudan University Shanghai China.
Abstract:
Functional subcellular organelle mitochondria are emerging as a crucial player and driver of cancer. For maintaining the sites of cellular respiration, mitochondria experience production, and accumulation of reactive oxygen species (ROS) underlying oxidative damage in electron transport chain carriers. Precision medicine targeting mitochondria can change nutrient availability and redox homeostasis in cancer cells, which might represent a promising strategy for suppressing tumor growth. Herein, this review highlights how the modification capable of manipulating nanomaterials for ROS generation strategies can influence or compensate the state of mitochondrial redox homeostasis. We propose foresight to guide research and innovation with an overview of seminal work and discuss future challenges and our perspective on the commercialization of novel mitochondria-targeting agents.
Insights
Mitochondria play a key role in cancer. Targeting mitochondria with nanomaterials to control reactive oxygen species (ROS) offers a promising precision medicine strategy for cancer therapy.
Area of Science:
- Mitochondrial biology
- Cancer research
- Nanomedicine
Background:
- Mitochondria are vital for cellular respiration and are implicated in cancer progression.
- Mitochondria produce and accumulate reactive oxygen species (ROS), leading to oxidative damage.
- Mitochondrial dysfunction is a hallmark of cancer, influencing tumor growth and development.
Purpose of the Study:
- To review the role of mitochondria in cancer.
- To explore the potential of targeting mitochondria with nanomaterials for cancer therapy.
- To discuss strategies for manipulating mitochondrial redox homeostasis using ROS-generating nanomaterials.
Main Methods:
- Literature review of seminal work on mitochondria, cancer, and nanomaterials.
- Analysis of how nanomaterial modifications can influence ROS generation.
- Discussion of research challenges and commercialization perspectives for mitochondria-targeting agents.
Main Results:
- Mitochondria are central to cancer cell metabolism and survival.
- Reactive oxygen species (ROS) accumulation in mitochondria contributes to cancer development.
- Nanomaterials can be engineered to modulate mitochondrial ROS levels, impacting cancer cells.
Conclusions:
- Targeting mitochondrial redox homeostasis represents a viable precision medicine approach for cancer treatment.
- Engineered nanomaterials offer a platform for developing novel mitochondria-targeting cancer therapeutics.
- Further research and development are needed for the clinical translation of these agents.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitochondrial Membranes

